NL6919123A - - Google Patents

Info

Publication number
NL6919123A
NL6919123A NL6919123A NL6919123A NL6919123A NL 6919123 A NL6919123 A NL 6919123A NL 6919123 A NL6919123 A NL 6919123A NL 6919123 A NL6919123 A NL 6919123A NL 6919123 A NL6919123 A NL 6919123A
Authority
NL
Netherlands
Application number
NL6919123A
Other versions
NL159974C (nl
NL159974B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6919123A publication Critical patent/NL6919123A/xx
Publication of NL159974B publication Critical patent/NL159974B/xx
Application granted granted Critical
Publication of NL159974C publication Critical patent/NL159974C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL6919123.A 1968-12-20 1969-12-19 Werkwijze ter bereiding van farmaceutische preparaten met diuretische en saluretische werking op basis van benzeen- sulfonamide-derivaten, aldus verkregen gevormde preparaten en werkwijze ter bereiding van hiervoor geschikte benzeen- sulfonamide-derivaten. NL159974C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1815922A DE1815922C3 (de) 1968-12-20 1968-12-20 5-Phenyltetrazol-Derivate

Publications (3)

Publication Number Publication Date
NL6919123A true NL6919123A (cg-RX-API-DMAC7.html) 1970-06-23
NL159974B NL159974B (nl) 1979-04-17
NL159974C NL159974C (nl) 1979-09-17

Family

ID=5716852

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6919123.A NL159974C (nl) 1968-12-20 1969-12-19 Werkwijze ter bereiding van farmaceutische preparaten met diuretische en saluretische werking op basis van benzeen- sulfonamide-derivaten, aldus verkregen gevormde preparaten en werkwijze ter bereiding van hiervoor geschikte benzeen- sulfonamide-derivaten.

Country Status (9)

Country Link
US (1) US3665002A (cg-RX-API-DMAC7.html)
AT (3) AT294086B (cg-RX-API-DMAC7.html)
CA (1) CA954512A (cg-RX-API-DMAC7.html)
CH (1) CH535244A (cg-RX-API-DMAC7.html)
DE (1) DE1815922C3 (cg-RX-API-DMAC7.html)
FI (1) FI49619C (cg-RX-API-DMAC7.html)
FR (1) FR2026688B1 (cg-RX-API-DMAC7.html)
GB (1) GB1237790A (cg-RX-API-DMAC7.html)
NL (1) NL159974C (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100912A1 (cg-RX-API-DMAC7.html) * 1970-07-15 1972-03-24 Boehringer Mannheim Gmbh

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991188A (en) * 1972-07-01 1976-11-09 Boehringer Mannheim G.M.B.H. 3-Alkyl-4-sulfamoyl-aniline therapeutic compositions
DE2232457A1 (de) * 1972-07-01 1974-01-10 Boehringer Mannheim Gmbh Neue 3-alkyl-4-sulfamoylanilinderivate
DE2423606A1 (de) * 1974-05-15 1975-11-27 Boehringer Mannheim Gmbh Pharmazeutisches praeparat
US3894033A (en) * 1974-05-16 1975-07-08 Pfizer 5-Aryltetrazoles
DE3034664A1 (de) * 1980-09-13 1982-05-06 Boehringer Mannheim Gmbh, 6800 Mannheim Verbessertes verfahren zur herstellung von 5-(4'-chlor-5'-sulfamoyl-2'-thenylamino)-phenyl-tetrazol
DE3041812A1 (de) * 1980-11-06 1982-06-16 Hoechst Ag, 6000 Frankfurt Basisch substituierte 5-phenyltetrazole, verfahren zu ihrer herstellung und ihre verwendung als heilmittel
DE4228926A1 (de) * 1992-08-31 1994-03-03 Boehringer Mannheim Gmbh Spritzfertige Azosemid-Injektionslösungen
IT1288123B1 (it) 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
DE10112040A1 (de) * 2001-03-14 2002-10-02 Aventis Pharma Gmbh Verbessertes Verfahren zur Herstellung von Sulfonylcarboxamidderivaten
EA200500234A1 (ru) 2002-08-19 2005-08-25 Пфайзер Продактс Инк. Комбинированная терапия гиперпролиферативных болезней
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US20080275093A1 (en) * 2004-11-15 2008-11-06 Nitromed, Inc. Diuretic Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
US20070149526A1 (en) * 2005-10-17 2007-06-28 Neurotherapeutics Pharma, L.L.C. Diuretic and diuretic-like compound analogs
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
WO2013021660A1 (ja) * 2011-08-08 2013-02-14 株式会社 三和化学研究所 アゾセミドを有効成分とするコーティング製剤
EP2887806B1 (en) 2012-07-20 2019-11-13 University Of Rochester Method of treating and preventing brain impairment using na+-k+ -2ci- cotransporter isoform 1 inhibitors
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1174797B (de) * 1962-10-16 1964-07-30 Hoechst Ag Verfahren zur Herstellung von Sulfamylanthranilsaeuren

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100912A1 (cg-RX-API-DMAC7.html) * 1970-07-15 1972-03-24 Boehringer Mannheim Gmbh

Also Published As

Publication number Publication date
AT294085B (de) 1971-11-10
GB1237790A (en) 1971-06-30
CH535244A (de) 1973-03-31
FI49619C (fi) 1975-08-11
AT294084B (de) 1971-11-10
FI49619B (cg-RX-API-DMAC7.html) 1975-04-30
US3665002A (en) 1972-05-23
AT294086B (de) 1971-11-10
FR2026688A1 (cg-RX-API-DMAC7.html) 1970-09-18
DE1815922B2 (de) 1978-08-03
FR2026688B1 (cg-RX-API-DMAC7.html) 1974-02-22
NL159974C (nl) 1979-09-17
DE1815922C3 (de) 1979-04-26
DE1815922A1 (de) 1970-06-25
CA954512A (en) 1974-09-10
NL159974B (nl) 1979-04-17

Similar Documents

Publication Publication Date Title
AU1946070A (cg-RX-API-DMAC7.html)
FR2026688B1 (cg-RX-API-DMAC7.html)
AU428130B2 (cg-RX-API-DMAC7.html)
AU2374870A (cg-RX-API-DMAC7.html)
AU5184069A (cg-RX-API-DMAC7.html)
AU6168869A (cg-RX-API-DMAC7.html)
AU6171569A (cg-RX-API-DMAC7.html)
AU4304568A (cg-RX-API-DMAC7.html)
AU2581067A (cg-RX-API-DMAC7.html)
AU2952567A (cg-RX-API-DMAC7.html)
AU4811568A (cg-RX-API-DMAC7.html)
AU421558B1 (cg-RX-API-DMAC7.html)
AR203075Q (cg-RX-API-DMAC7.html)
AU4744468A (cg-RX-API-DMAC7.html)
AU2580267A (cg-RX-API-DMAC7.html)
AU3224368A (cg-RX-API-DMAC7.html)
AU3083868A (cg-RX-API-DMAC7.html)
BE725056A (cg-RX-API-DMAC7.html)
BE581157A (cg-RX-API-DMAC7.html)
BE709446A (cg-RX-API-DMAC7.html)
BE727483A (cg-RX-API-DMAC7.html)
BE722350A (cg-RX-API-DMAC7.html)
BE709479A (cg-RX-API-DMAC7.html)
AU2889368A (cg-RX-API-DMAC7.html)
BE726338A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: BOEHRINGER

V4 Discontinued because of reaching the maximum lifetime of a patent